Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Submission is supported by 24-week results from the Phase 3b APEX study in adults with active psoriatic arthritis treated with TREMFYA ® , the only dual-acting IL-23 inhibitor HORSHAM, Pa. , J
2 Unstoppable Dow Dividend Stocks to Buy and Hold Forever
08:29pm, Monday, 28'th Jul 2025
The Dow Jones Industrial Average tracks 30 of the country's top companies. These mature companies tend to be very profitable, enabling them to pay sustainable dividends.
Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever
08:05pm, Monday, 28'th Jul 2025
Healthcare stocks aren't exactly known for offering large yields, with the average healthcare stock at just 1.8% or so. You can do better than that and get reliable dividend stocks while you are at it
5 Dogs of the Dow Are Crushing the S&P 500 and Nasdaq in 2025
02:45pm, Monday, 28'th Jul 2025
The Dogs of the Dow is a well-known strategy first published in 1991 by Michael O'Higgins.
3 Top Dividend Kings I'm Planning on Buying
12:34pm, Sunday, 27'th Jul 2025
Finding dividend stocks that are reliable and have the balance sheet stability and cash flow profile to continue to grow their distributions over the long-term is what many investors are after.
22 Dividend Kings At Discounted Valuations
12:14pm, Sunday, 27'th Jul 2025
Dividend kings can offer reliable income growth and capital appreciation, making them attractive for long-term investors. During our screening today, we have 22 dividend kings trading at what could be
20 Kiplinger July Dividend Favorites: No Cigars
11:45am, Sunday, 27'th Jul 2025
Dividend stocks are regaining appeal as interest rates fall, offering higher returns and lower risk compared to non-dividend payers over the long term. Top Kiplinger dividend 'dogs' are projected to d
These 3 Dow Stocks Are Set to Soar in 2025 and Beyond
03:15am, Sunday, 27'th Jul 2025
This is a tricky time for investors. Most people agree that valuations have reached alarmingly high levels.
US FDA says J&J's Ethicon issues correction related to surgical stapler
11:48am, Friday, 25'th Jul 2025
The U.S. drug regulator said on Friday Ethicon Endo-Surgery, a unit of Johnson & Johnson , issued a correction for certain lots of a part related to its surgical stapler and classified the action as "
Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference
04:30pm, Thursday, 24'th Jul 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3rd, 2025. Management will participate in a Fires
Why Johnson & Johnson (JNJ) is a Top Momentum Stock for the Long-Term
10:50am, Thursday, 24'th Jul 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
J&J Innovative Medicine Unit Shines Again in Q2: Will This Continue?
10:25am, Thursday, 24'th Jul 2025
JNJ's Innovative Medicine unit posts solid Q2 growth despite Stelara's LOE, powered by Darzalex, Tremfya, Erleada and new drugs.
How To Build A $100,000 Dividend Portfolio: Targeting A Yield Of 15%+ In 20 Years
06:00pm, Wednesday, 23'rd Jul 2025
The Dividend Income Accelerator Portfolio delivers a 3.98% yield and 7.11% five-year dividend growth, balancing income and growth for strong risk-adjusted returns. Our portfolio is globally diversifie
I Switched from Mutual Funds to These 3 ETFs—Here’s Why
04:10pm, Wednesday, 23'rd Jul 2025
Key Points ETFs have generated higher returns than mutual funds. GLD, VYM, and QQQ have the potential to outpace S&P 500. Are you ahead, or behind on retirement? SmartAsset’s free tool can match
How to Build a Super Low Cost Passive Income Fund for Only $25,000
04:10pm, Wednesday, 23'rd Jul 2025
Key Points The RSPA ETF will immediately turn the bulk of your $25,000 account into a diversified income machine. Smaller allocations into SCHD, JEPQ, and FDVV will help you build a low-fee passive in
